Nadir Arber
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Nadir Arber has a total of 247 co-authors. Here are the top co-authors by number of shared publications:
- Sarah Kraus
Tel Aviv University, Tel Aviv, Israel
25 shared publications Shiran Shapira
22 shared publicationsDiana Kazanov
21 shared publicationsInna Naumov
16 shared publicationsDina Kazanov
10 shared publicationsLior Galazan
9 shared publications
Latest Publications
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
191 - “Gammora”: Selective Eradication of Cancer Cells Bearing CD24 by Viral Integrase
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
191 - “Gammora”: Selective Eradication of Cancer Cells Bearing CD24 by Viral Integrase
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
134 - Prepless CRC Screening is Feasible with a Novel X-Ray Imaging Capsule
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
134 - Prepless CRC Screening is Feasible with a Novel X-Ray Imaging Capsule
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Sa1663 - Direct Interaction of Cd24 with B-Catenin on the Cellular Membrane Plays a Major Role in Intestinal Tumorigenesis
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Sa1663 - Direct Interaction of Cd24 with B-Catenin on the Cellular Membrane Plays a Major Role in Intestinal Tumorigenesis
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S640-S641
Use of a Combination of Lentivirus Particles and a Specific Peptide for Eradication of CD24-Expressing Malignant Cells: A Novel Approach for Cancer Therapy
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S640-S641
Use of a Combination of Lentivirus Particles and a Specific Peptide for Eradication of CD24-Expressing Malignant Cells: A Novel Approach for Cancer Therapy
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S426
A Novel Capsule Technology Platform for Specific Localized Colon Drug Delivery
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S426
A Novel Capsule Technology Platform for Specific Localized Colon Drug Delivery
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S533-S534
Gilbert Syndrome is not That Innocent!
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S533-S534
Gilbert Syndrome is not That Innocent!
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S41-S42
Selective Eradication of K-Ras Mutated Cancer Cells by Delivery of Bacterial Toxins
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S41-S42
Selective Eradication of K-Ras Mutated Cancer Cells by Delivery of Bacterial Toxins
- 20 May 2016
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (15_suppl) , 1555
One stop screening for multiple cancer types: 10 year experience of an integrated cancer prevention center.
1555 Background: Cancer is the leading cause of mortality worldwide. Prevention and early detection are the pivotal tools for reducing cancer morbidity and mortality. Methods: We describe the 10 year experience (2006-2015) of an integrated cancer prevention center that provides screening for prevention and early detection of 11 cancer types (table) for healthy individuals (age 20-80 years). Extensive clinical and epidemiological data was obtained from all patients. Peripheral blood DNA was extracted from all participants and the APC I1307K and APC E1317Q polymorphisms were genotyped in all participants. Results: A total of 5022 (49%) men and 5217 (51%) women mean age 47.2±11.5 years were screened. Malignant lesions were detected in 355 (3.5%) of screenees. The most common cancers were skin (159, 1.6%), breast (44, 0.4%), gastrointestinal tract (43, 0.4%), gynecological (31, 0.3%) and male reproductive system (30, 0.3%). Forty four patients (0.4%) had more than one cancer. The APC I1307K and E1317Q variants were detected in 456 (5.6%) and 146 (1.4%) subjects respectively. First degree family member with cancer, I1307K carriership, alcohol intake, female gender, smoking and advanced age were all associated with increased cancer risk (Table). Family history of cancer in first degree relative and advanced age were also associated with increased risk for multiple malignancies. Conclusions: One stop shop screening for 11 common cancers in the setting of a multidisciplinary outpatient clinic is feasible and can prevent and detect cancer at an early stage and improve morbidity and mortality of the number one terrorist world-wide. Clinical trial information: 04-474.
- 20 May 2016
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (15_suppl) , 1555
One stop screening for multiple cancer types: 10 year experience of an integrated cancer prevention center.
1555 Background: Cancer is the leading cause of mortality worldwide. Prevention and early detection are the pivotal tools for reducing cancer morbidity and mortality. Methods: We describe the 10 year experience (2006-2015) of an integrated cancer prevention center that provides screening for prevention and early detection of 11 cancer types (table) for healthy individuals (age 20-80 years). Extensive clinical and epidemiological data was obtained from all patients. Peripheral blood DNA was extracted from all participants and the APC I1307K and APC E1317Q polymorphisms were genotyped in all participants. Results: A total of 5022 (49%) men and 5217 (51%) women mean age 47.2±11.5 years were screened. Malignant lesions were detected in 355 (3.5%) of screenees. The most common cancers were skin (159, 1.6%), breast (44, 0.4%), gastrointestinal tract (43, 0.4%), gynecological (31, 0.3%) and male reproductive system (30, 0.3%). Forty four patients (0.4%) had more than one cancer. The APC I1307K and E1317Q variants were detected in 456 (5.6%) and 146 (1.4%) subjects respectively. First degree family member with cancer, I1307K carriership, alcohol intake, female gender, smoking and advanced age were all associated with increased cancer risk (Table). Family history of cancer in first degree relative and advanced age were also associated with increased risk for multiple malignancies. Conclusions: One stop shop screening for 11 common cancers in the setting of a multidisciplinary outpatient clinic is feasible and can prevent and detect cancer at an early stage and improve morbidity and mortality of the number one terrorist world-wide. Clinical trial information: 04-474.
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S364-S365
Sa1781 CD24 Induces the Activation of β-catenin in Intestinal Tumorigenesis
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S364-S365
Sa1781 CD24 Induces the Activation of β-catenin in Intestinal Tumorigenesis
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S601-S602
Su1967 CD24 KO Male Mice As a Model System of Early Onset Obesity in Men With Insulin Hyper-Sensitivity
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S601-S602
Su1967 CD24 KO Male Mice As a Model System of Early Onset Obesity in Men With Insulin Hyper-Sensitivity